Tag Archives: U.S.

Can psychedelics treat anorexia, depression? U.S. scientists get millions to find out

Since childhood, Rachael Petersen had lived with an unexplainable sense of grief that no drug or talk therapy could entirely ease. So in 2017 she volunteered for a small clinical trial at Johns Hopkins University that was testing psilocybin, the active ingredient in magic mushrooms, for chronic depression. “I was so depressed,” Petersen, 29, said… Read More »

Amgen wins U.S. patent battle on arthritis drug Enbrel, thwarting Novartis

(Reuters) – A U.S. judge on Friday upheld two patents relating to Amgen Inc’s blockbuster rheumatoid arthritis drug Enbrel, denying a challenge by Novartis AG, which is seeking to launch a copycat version. FILE PHOTO: An Amgen sign is seen at the company’s office in South San Francisco, California in this October 21, 2013 file… Read More »

U.S. Conference on AIDS to Address Trump’s HIV Plan for America

In a year that saw the introduction of President Trump’s “Ending the HIV Epidemic: A Plan for America,” it is only fitting that the United States Conference on AIDS (USCA), held at a different city each year, will take place in Washington, DC, and focus on the structure, implementation and feasibility of Trump’s federal initiative.… Read More »

Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva

NEW YORK (Reuters) – A top U.S. pharmacy benefit manager (PBM) owned by UnitedHealth Group Inc has included new migraine drugs from Amgen Inc and Eli Lilly and Co as preferred treatments on its lists of covered drugs, according to an OptumRx client note viewed by Reuters. FILE PHOTO: The logo of Lilly is seen… Read More »